title: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
authors.affiliation: Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania.
authors.forename: Dan
authors.initials: D
authors.lastname: Călugăru
authors.affiliation: Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania. mihai.calugaru@mail.dntcj.ro.
authors.forename: Mihai
authors.initials: M
authors.lastname: Călugăru
mesh_terms: D000068258:Bevacizumab; D003930:Diabetic Retinopathy; D006801:Humans; D008269:Macular Edema; D040262:Receptors, Vascular Endothelial Growth Factor; D011993:Recombinant Fusion Proteins
chemical_list: D011993:Recombinant Fusion Proteins; C533178:aflibercept; D000068258:Bevacizumab; D040262:Receptors, Vascular Endothelial Growth Factor